Keeney Adam has filed 19 insider transactions across 1 company since May 2023.
Most recent transaction: a grant/award of 8025 shares of BIOGEN INC. ($BIIB) on February 13, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 13, 2026 | BIOGEN INC. | $BIIB | Keeney Adam | Head of Corporate Development | A | Restricted Stock Unit | 8025 | $0.00 | 8,025.0000 | 170,500,000 | 9999.99% | 0.00% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Keeney Adam | Head of Corporate Development | F | Common Stock | 589 | $201.18 | 3,597.0000 | 170,500,000 | 14.07% | 0.00% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Keeney Adam | Head of Corporate Development | M | Common Stock | 1802 | $0.00 | 4,186.0000 | 170,500,000 | 75.59% | 0.00% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Keeney Adam | Head of Corporate Development | M | Common Stock | 3278 | $0.00 | 6,875.0000 | 170,500,000 | 91.13% | 0.00% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Keeney Adam | Head of Corporate Development | M | Restricted Stock Unit | 3278 | $0.00 | 6,557.0000 | 170,500,000 | 33.33% | 0.00% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Keeney Adam | Head of Corporate Development | M | Restricted Stock Unit | 1802 | $0.00 | 1,802.0000 | 170,500,000 | 50.00% | 0.00% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Keeney Adam | Head of Corporate Development | F | Common Stock | 994 | $201.18 | 5,881.0000 | 170,500,000 | 14.46% | 0.00% |
| May 1, 2025 | BIOGEN INC. | $BIIB | Keeney Adam | Head of Corporate Development | M | Common Stock | 938 | $0.00 | 2,838.0000 | 169,500,000 | 49.37% | 0.00% |
| May 1, 2025 | BIOGEN INC. | $BIIB | Keeney Adam | Head of Corporate Development | F | Common Stock | 454 | $120.93 | 2,384.0000 | 169,500,000 | 16.00% | 0.00% |
| May 1, 2025 | BIOGEN INC. | $BIIB | Keeney Adam | Head of Corporate Development | M | Restricted Stock Unit | 938 | $0.00 | 939.0000 | 169,500,000 | 49.97% | 0.00% |
| Feb. 7, 2025 | BIOGEN INC. | $BIIB | Keeney Adam | Head of Corporate Development | F | Common Stock | 563 | $141.35 | 1,900.0000 | 169,500,000 | 22.86% | 0.00% |
| Feb. 7, 2025 | BIOGEN INC. | $BIIB | Keeney Adam | Head of Corporate Development | M | Restricted Stock Unit | 1801 | $0.00 | 3,604.0000 | 169,500,000 | 33.32% | 0.00% |
| Feb. 6, 2025 | BIOGEN INC. | $BIIB | Keeney Adam | Head of Corporate Development | A | Restricted Stock Unit | 9835 | $0.00 | 9,835.0000 | 169,500,000 | 9999.99% | 0.01% |
| Feb. 7, 2025 | BIOGEN INC. | $BIIB | Keeney Adam | Head of Corporate Development | M | Common Stock | 1801 | $0.00 | 2,463.0000 | 169,500,000 | 272.05% | 0.00% |
| May 1, 2024 | BIOGEN INC. | $BIIB | Keeney Adam | Head of Corporate Development | M | Common Stock | 938 | $0.00 | 938.0000 | 168,700,000 | 9999.99% | 0.00% |
| May 1, 2024 | BIOGEN INC. | $BIIB | Keeney Adam | Head of Corporate Development | M | Restricted Stock Unit | 938 | $0.00 | 1,877.0000 | 168,700,000 | 33.32% | 0.00% |
| May 1, 2024 | BIOGEN INC. | $BIIB | Keeney Adam | Head of Corporate Development | F | Common Stock | 276 | $216.13 | 662.0000 | 168,700,000 | 29.42% | 0.00% |
| Feb. 7, 2024 | BIOGEN INC. | $BIIB | Keeney Adam | Head of Corporate Development | A | Restricted Stock Unit | 5405 | $0.00 | 5,405.0000 | 168,700,000 | 9999.99% | 0.00% |
| May 1, 2023 | BIOGEN INC. | $BIIB | Keeney Adam | Head of Corporate Development | A | Restricted Stock Unit | 2815 | $0.00 | 2,815.0000 | 167,900,000 | 9999.99% | 0.00% |